Eculizumab and MFV

    • Anonymous
      May 3, 2008 at 9:14 am

      Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model

      Anti-GQ1b ganglioside antibodies are the serological hallmark of the Miller Fisher syndrome (MFS) variant of the paralytic neuropathy, Guillain–Barré syndrome, and are believed to be the principal pathogenic mediators of the disease. In support of this, we previously showed in an in vitro mouse model of MFS that anti-GQ1b antibodies were able to bind and disrupt presynaptic motor nerve terminals at the neuromuscular junction (NMJ) as one of their target sites, thereby causing muscle paralysis.

      cut and paste the following link: